comparemela.com

Latest Breaking News On - Artrya limited - Page 1 : comparemela.com

Artrya Advances Toward FDA Approval

Artrya Limited (AU:AYA) has released an update. Artrya Limited, an Australian AI healthcare company, has progressed its efforts to gain FDA approva.

Artrya Expands Global Footprint in Heart Disease AI

Artrya Limited (AU:AYA) has released an update. Artrya Limited has initiated commercial operations in Australia, partnering with The Cardiac Centre.

12,000,000 Options of Artrya Limited are subject to a Lock-Up Agreement Ending on 26-NOV-2023

12,000,000 Options of Artrya Limited are subject to a Lock-Up Agreement Ending on 26-NOV-2023. These Options will be under lockup for 732 days starting from 24-NOV-2021 to.

Artrya Limited (ASX:AYA) Insider Buys A$96,000 00 in Stock

Artrya Limited (ASX:AYA – Get Rating) insider Bernard (Bernie) Ridgeway acquired 300,000 shares of the company’s stock in a transaction on Friday, March 31st. The stock was acquired at an average price of A$0.32 ($0.22) per share, for a total transaction of A$96,000.00 ($65,306.12). Artrya Price Performance The company has a debt-to-equity ratio of 3.51, […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.